STERIS plc (NYSE:STE) Stock Holdings Lifted by NEOS Investment Management LLC

NEOS Investment Management LLC raised its position in shares of STERIS plc (NYSE:STE) by 30.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,374 shares of the medical equipment provider’s stock after purchasing an additional 1,243 shares during the period. NEOS Investment Management LLC’s holdings in STERIS were worth $1,105,000 as of its most recent SEC filing.

Several other institutional investors have also made changes to their positions in the company. Raymond James Financial Inc. acquired a new stake in STERIS in the fourth quarter valued at approximately $223,987,000. Franklin Resources Inc. raised its holdings in shares of STERIS by 171.2% during the 3rd quarter. Franklin Resources Inc. now owns 838,569 shares of the medical equipment provider’s stock valued at $191,370,000 after purchasing an additional 529,308 shares in the last quarter. Boston Trust Walden Corp lifted its stake in shares of STERIS by 400.4% in the 4th quarter. Boston Trust Walden Corp now owns 224,741 shares of the medical equipment provider’s stock valued at $46,198,000 after purchasing an additional 179,829 shares during the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. boosted its holdings in STERIS by 15.9% in the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,261,927 shares of the medical equipment provider’s stock worth $257,585,000 after purchasing an additional 172,795 shares in the last quarter. Finally, Benjamin Edwards Inc. increased its position in STERIS by 2,123.2% during the third quarter. Benjamin Edwards Inc. now owns 113,672 shares of the medical equipment provider’s stock worth $27,574,000 after buying an additional 108,559 shares during the last quarter. 94.69% of the stock is currently owned by institutional investors and hedge funds.

STERIS Price Performance

NYSE STE opened at $222.99 on Friday. The stock has a 50-day simple moving average of $222.51 and a 200 day simple moving average of $221.30. STERIS plc has a twelve month low of $197.82 and a twelve month high of $248.24. The stock has a market capitalization of $21.91 billion, a PE ratio of 47.34 and a beta of 0.92. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.40 and a current ratio of 2.13.

STERIS (NYSE:STE) last issued its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 EPS for the quarter, missing analysts’ consensus estimates of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. Research analysts anticipate that STERIS plc will post 9.08 EPS for the current year.

STERIS Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 21st. Stockholders of record on Thursday, February 20th were issued a dividend of $0.57 per share. The ex-dividend date of this dividend was Thursday, February 20th. This represents a $2.28 annualized dividend and a dividend yield of 1.02%. STERIS’s payout ratio is 48.41%.

Analyst Upgrades and Downgrades

STE has been the subject of several recent analyst reports. Piper Sandler upped their price target on STERIS from $260.00 to $265.00 and gave the stock an “overweight” rating in a research note on Monday, February 3rd. JMP Securities reaffirmed a “market outperform” rating and set a $265.00 target price on shares of STERIS in a research report on Thursday, February 6th. Finally, Stephens reissued an “overweight” rating and issued a $240.00 price target on shares of STERIS in a research report on Thursday, February 6th. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $258.75.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.